Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Meiosis-expressed gene 1 protein homolog (MEIG1) is a small, highly conserved protein essential for spermiogenesis, the final stage of sperm formation during spermatogenesis[1][2][4][6]. MEIG1 is initially found throughout spermatocytes and round spermatids but relocates to the manchette—a microtubular structure in elongating spermatids—through its interaction with the Parkin co-regulated gene protein (PACRG)[1][4][5]. The MEIG1–PACRG complex is crucial for targeting and transporting proteins necessary for sperm flagellum assembly[1][3][5]. Loss of MEIG1 disrupts manchette integrity, impairs sperm tail formation, and causes male infertility, but does not affect meiosis directly[2][3][5]. MEIG1 does not belong to a classic family such as kinases, receptors, or enzymes, and currently is not considered a therapeutic drug target, though its protein–protein interface has been proposed as a target for male contraception research[4]. There are no known drugs or clinical biomarkers tied to MEIG1, and no notable safety concerns associated except loss-of-function leading to infertility.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Meiosis-expressed gene 1 protein homolog (MEIG1).